• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[长期生存的小细胞肺癌:一例报告并文献复习]

[Small-cell lung carcinoma with long-term survival: a case report and review of the literature].

作者信息

Lü C, Zhu T, Fan S, Wu X, Xia Q

机构信息

Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Department of Oncology, Punan Hospital of Pudong New District, Shanghai 200120, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2152-2157. doi: 10.12122/j.issn.1673-4254.2023.12.22.

DOI:10.12122/j.issn.1673-4254.2023.12.22
PMID:38189404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10774097/
Abstract

We report a rare case of small-cell lung carcinoma with long-term survival treated in the Department of Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine. The pathological-clinical features and diagnosis-treatment progress were analyzed, and the comprehensive treatment strategies, tumor heterogeneity and prognosis of this tumor type were discussed by comparing with other previous studies. The 62-year-old patient was diagnosed with small-cell lung carcinoma and received surgery, radiotherapy and multi-line treatment, and had survived for 13 years after the surgery. The heterogeneity of small cell lung carcinoma should be carefully evaluated to improve the prognosis of the patients.

摘要

我们报告了上海交通大学医学院附属仁济医院肿瘤科收治的一例小细胞肺癌长期生存的罕见病例。分析了其病理临床特征及诊治进展,并与既往其他研究进行比较,探讨了该肿瘤类型的综合治疗策略、肿瘤异质性及预后。该62岁患者被诊断为小细胞肺癌,接受了手术、放疗及多线治疗,术后存活13年。应仔细评估小细胞肺癌的异质性以改善患者预后。

相似文献

1
[Small-cell lung carcinoma with long-term survival: a case report and review of the literature].[长期生存的小细胞肺癌:一例报告并文献复习]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2152-2157. doi: 10.12122/j.issn.1673-4254.2023.12.22.
2
Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection.局限期小细胞肺癌综合治疗包括根治性切除术后的预后。
World J Surg Oncol. 2020 Feb 3;18(1):27. doi: 10.1186/s12957-020-1807-1.
3
[Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].8例原发性肺淋巴上皮瘤样癌的临床分析
Zhongguo Fei Ai Za Zhi. 2020 Mar 20;23(3):168-175. doi: 10.3779/j.issn.1009-3419.2020.03.06.
4
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.
5
Outcome and treatment strategy in female lung cancer: a single institution experience.女性肺癌的预后和治疗策略:单中心经验。
Adv Med Sci. 2010;55(2):273-80. doi: 10.2478/v10039-010-0044-1.
6
[Surgical Procedures and Perioperative Management for Non-small Cell Lung Cancer Complicated with Left Atrial Tumor Thrombus].非小细胞肺癌合并左心房肿瘤血栓的外科手术及围手术期管理
Zhongguo Fei Ai Za Zhi. 2018 Jan 20;21(1):24-31. doi: 10.3779/j.issn.1009-3419.2018.01.04.
7
[Treatment outcome of locally advanced stage IIIA/B lung cancer].[局部晚期IIIA/B期肺癌的治疗结果]
Medicina (Kaunas). 2009;45(6):452-9.
8
Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control.精神分裂症患者隐匿性小细胞肺癌单发脑转移的 3 年随访
Lung Cancer. 2010 Aug;69(2):245-8. doi: 10.1016/j.lungcan.2010.05.002.
9
Does surgery improve prognosis in patients with small-cell lung carcinoma?手术能改善小细胞肺癌患者的预后吗?
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):375-80. doi: 10.1093/icvts/ivs475. Epub 2012 Nov 20.
10
[A Case Report of Primary Pulmonary NUT Carcinoma and Literature Review].[原发性肺 NUT 癌 1 例报告并文献复习]
Zhongguo Fei Ai Za Zhi. 2021 Jan 20;24(1):63-68. doi: 10.3779/j.issn.1009-3419.2020.102.44.

本文引用的文献

1
Cancer incidence and mortality in China, 2016.2016年中国癌症的发病率和死亡率
J Natl Cancer Cent. 2022 Feb 27;2(1):1-9. doi: 10.1016/j.jncc.2022.02.002. eCollection 2022 Mar.
2
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.单细胞转录组谱分析揭示了小细胞肺癌的肿瘤异质性。
Signal Transduct Target Ther. 2022 Oct 5;7(1):346. doi: 10.1038/s41392-022-01150-4.
3
Small cell lung cancer: Novel treatments beyond immunotherapy.小细胞肺癌:免疫治疗之外的新疗法。
Semin Cancer Biol. 2022 Nov;86(Pt 2):376-385. doi: 10.1016/j.semcancer.2022.05.004. Epub 2022 May 11.
4
Safety and efficacy of ICI plus anlotinib vs. anlotinib alone as third-line treatment in extensive-stage small cell lung cancer: a retrospective study.ICI 联合安罗替尼对比安罗替尼单药作为广泛期小细胞肺癌三线治疗的安全性和有效性:一项回顾性研究。
J Cancer Res Clin Oncol. 2022 Feb;148(2):401-408. doi: 10.1007/s00432-021-03858-2. Epub 2021 Nov 19.
5
Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.手术对 III 期 N2 小细胞肺癌患者生存的影响:倾向评分匹配分析和列线图的建立和验证。
World J Surg Oncol. 2021 Aug 30;19(1):258. doi: 10.1186/s12957-021-02364-6.
6
Overcoming Chemotherapy Resistance in SCLC.克服小细胞肺癌的化疗耐药性。
J Thorac Oncol. 2021 Dec;16(12):2002-2015. doi: 10.1016/j.jtho.2021.07.018. Epub 2021 Aug 3.
7
Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study.安罗替尼对比安慰剂用于小细胞肺癌三线或后线治疗的随机、双盲、安慰剂对照的 II 期研究。
Br J Cancer. 2021 Aug;125(3):366-371. doi: 10.1038/s41416-021-01356-3. Epub 2021 May 18.
8
Response to first-line treatment predicts progression-free survival benefit of small-cell lung cancer patients treated with anlotinib.一线治疗应答可预测安罗替尼治疗小细胞肺癌患者的无进展生存期获益。
Cancer Med. 2021 Jun;10(12):3896-3904. doi: 10.1002/cam4.3941. Epub 2021 May 6.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Small-cell lung cancer.小细胞肺癌。
Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0.